Perspectives of HPV immunoprophylaxis in women over forty

Tomasz Pertyński; Grzegorz Stachowiak; Agnieszka Zając

eISSN: 2299-0038
ISSN: 1643-8876

Menopause Review/Przegląd Menopauzalny

Current issue Archive Manuscripts accepted About the journal Special Issues Editorial board Abstracting and indexing Subscription Contact Instructions for authors Publication charge Ethical standards and procedures

Editorial System

Submit your Manuscript

Editorial Policies

Sarajevo Declaration on Integrity and Visibility of Scholarly Publications

Open access

5/2008
vol. 7

Send email

Copy url:

abstract:

Perspectives of HPV immunoprophylaxis in women over forty

Tomasz Pertyński

,

Grzegorz Stachowiak

,

Agnieszka Zając

Przegląd Menopauzalny 2008; 5: 237-241

Online publish date: 2008/10/29

View full text Get citation

Oncogenic and non-oncogenic HPV infections are a problem not only for women aged 20-30, but also for older ones, over forty. So, effective prophylactic actions in premenopausal women should include not only secondary prophylaxis, but also all possible elements of primary prophylaxis. Although the most important part of this prophylaxis – a HPV vaccine – does not apply at the moment to women over forty, the preliminary results of FUTURE III – testifying to the high efficacy of the quadrivalent vaccine (HPV 6, 11, 16 and 18) in the group of women aged 35-45 – allow us to presume that the administration of effective immunoprophylaxis in premenopausal women will be possible in the near future.

keywords:

Perspectives of HPV immunoprophylaxis in women over forty

Tomasz Pertyński , Grzegorz Stachowiak , Agnieszka Zając

HPV, immunoprophylaxis, menopause, cervical carcinoma

Tomasz Pertyński

,

Grzegorz Stachowiak

,

Agnieszka Zając